India's exports of active pharma ingredients at ₹41,500 cr surpassed imports in FY25

In the fiscal year 2025, India achieved a significant milestone in its pharmaceutical sector, with exports of active pharmaceutical ingredients (APIs) reaching ₹41,500 crore, surpassing the value of imports. This accomplishment highlights India's growing role as a global player in the pharmaceutical industry, particularly in the production and supply of essential medicines. The increase in API exports is attributed to heightened demand from international markets and the country's robust manufacturing capabilities. The Indian pharmaceutical sector has been expanding rapidly, supported by government initiatives aimed at boosting production and enhancing export competitiveness. This trend not only reinforces India's position as a major supplier of pharmaceuticals worldwide but also aids in reducing dependency on foreign imports, thereby contributing positively to the nation's trade balance. As the global healthcare landscape evolves, the focus on self-reliance in pharmaceutical production is becoming increasingly paramount for India, positioning the country for sustained growth in this vital sector.